Cystic Fibrosis



A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects


Condition:   Cystic Fibrosis
Interventions:   Drug: FDL169;   Drug: Placebo
Sponsor:   Flatley Discovery Lab LLC
Not yet recruiting - verified March 2017


Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis


Condition:   Cystic Fibrosis
Interventions:   Drug: Tobi Inhalant Product;   Drug: Nebcin
Sponsor:   University Hospital, Lille
Not yet recruiting - verified March 2017


Clearance of 25-hydroxyvitamin D in Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Drug: d6-25-hydroxyvitamin D3
Sponsors:   University of Washington;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2017


The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis


Condition:   Cystic Fibrosis
Interventions:   Drug: Oral Glutathione;   Drug: Placebo
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Cystic Fibrosis Foundation Therapeutics
Not yet recruiting - verified March 2017


Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Other: cardiopulmonary exercise testing
Sponsor:   University Hospital, Lille
Recruiting - verified December 2016


Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation)


Condition:   Cystic Fibrosis
Interventions:   Drug: GLPG1837 dose 1;   Drug: GLPG1837 dose 2;   Drug: GLPG1837 dose 3
Sponsor:   Galapagos NV
Completed - verified March 2016


Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)


Condition:   Cystic Fibrosis
Interventions:   Drug: GLPG1837 dose 1;   Drug: GLPG1837 dose 2
Sponsor:   Galapagos NV
Completed - verified March 2016


Integrating Supportive Care in Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Behavioral: Supportive Care Intervention
Sponsors:   University of Pittsburgh;   Cystic Fibrosis Foundation Therapeutics
Recruiting - verified May 2017


Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis


Condition:   Pulmonary Cystic Fibrosis
Interventions:   Other: Placebo;   Drug: QBW276
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting - verified May 2017


6 Minute Walk Test in Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Other: 6-minute walk test
Sponsors:   Assistance Publique - Hôpitaux de Paris;   Data analysis : EFFI-STAT (statistic expert);   Methodologist : URC-CIC-Paris Descartes;   Funding : Association Vaincre La Mucoviscidose
Recruiting - verified July 2016


Puberty in Girls Followed for Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Procedure: Data collection
Sponsor:   University Hospital, Toulouse
Completed - verified March 2017


Electrical Impedance Imaging of Patients With Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:   Device: CT scan
Sponsors:   Colorado State University;   Children's Hospital Colorado;   University of Colorado, Denver
Enrolling by invitation - verified July 2016


Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)


Condition:   Cystic Fibrosis
Intervention:   Drug: ivacaftor
Sponsor:   Vertex Pharmaceuticals Incorporated
Recruiting - verified December 2016


Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis


Condition:   Cystic Fibrosis
Interventions:   Device: High-Flow, 20 LPM (via Optiflow cannula);   Device: Low FLow, 5 LPM (via Optiflow cannula)
Sponsor:   Virginia Commonwealth University
Recruiting - verified January 2017


Cystic Fibrosis- Children and Adults Tai Chi Study


Condition:   Cystic Fibrosis
Intervention:   Other: Tai chi
Sponsors:   London South Bank University;   Royal Brompton & Harefield NHS Foundation Trust
Active, not recruiting - verified September 2016


Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation


Condition:   Cystic Fibrosis
Intervention:   Drug: Ivacaftor
Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation Therapeutics
Completed - verified December 2016


An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis


Condition:   Cystic Fibrosis
Interventions:   Other: Ophthalmologic examinations;   Drug: Ivacaftor Exposed
Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation Therapeutics
Completed - verified July 2015


Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.


Condition:   Cystic Fibrosis
Intervention:  
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed - verified July 2016


Correlation Between Haptoglobin Phenotypes and Infectious and Other Complications in Cystic Fibrosis Patients


Condition:   Cystic Fibrosis
Intervention:   Other: no intervention
Sponsor:   Carmel Medical Center
Completed - verified July 2016


Quantitative Computed Tomodensitometry in Patients With Cystic Fibrosis


Condition:   Cystic Fibrosis
Interventions:   Other: QCT;   Other: DXA
Sponsors:   Hôpital Necker-Enfants Malades;   Vaincre la Mucoviscidose
Active, not recruiting - verified June 2016


Costimulatory Molecules as Biomarkers in Cystic Fibrosis


Condition:   Cystic Fibrosis
Intervention:  
Sponsor:   Oregon Health and Science University
Completed - verified April 2017


28 Day Repeat Dose in Cystic Fibrosis Patients


Condition:   Cystic Fibrosis
Interventions:   Drug: SB656933;   Drug: SB656933;   Drug: Placebo
Sponsor:   GlaxoSmithKline
Completed - verified January 2017


RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum


Condition:   Cystic Fibrosis
Intervention:   Drug: Pulmozyme
Sponsor:   University Hospital, Tours
Completed - verified February 2017


Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings


Condition:   Cystic Fibrosis
Interventions:   Device: HFCWC with higher pressure/variable-frequency settings;   Device: HFCWC with lower pressure/mid-frequency settings
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   Hill-Rom
Completed - verified June 2016


Absorptive Clearance in the Cystic Fibrosis Airway


Condition:   Cystic Fibrosis
Intervention:   Other: Technetium [Tc-99m] sulfur colloid and Indium [In-111] DTPA
Sponsor:   University of Pittsburgh
Completed - verified April 2017

Refine Your Search Advanced Search